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===================

Infection of human gastric mucosae with*Helicobacter pylori* is the major known risk factor for gastric cancer ([@B1], [@B2]), a disease that killed an estimated 723,000 people worldwide in 2012 and is the third most common cause of cancer deaths ([@B3]). Infection is typically acquired in childhood, and about half of the world's population is infected. Although most infected persons have mild symptoms and no serious sequelae, a small proportion (1 to 3%) of those infected may develop gastric cancer. The series of lesions that may lead to the intestinal type of gastric cancer include nonatrophic gastritis, multifocal atrophic gastritis, intestinal metaplasia, and dysplasia ([@B4], [@B5]). Previously we reported that the disrupted coevolution of human hosts and *H. pylori* genomes is associated with more advanced gastric lesions in Colombian populations ([@B6]).

Here, we present draft genomes of 13 *H. pylori* strains isolated from residents of Tumaco (*n* = 6) on the Pacific coast, where incidence of gastric cancer is low, and from residents of Túquerres (*n* = 7) in the Andes mountains, where incidence is high. All participants provided informed consent; the study was approved by the institutional review boards of Vanderbilt University Medical Center and of the local hospitals. Participants were 40 years of age or older and were genotyped using the Immunochip ([@B7]), as previously described ([@B6]), to estimate ancestry ([Table 1](#tab1){ref-type="table"}). Diagnosis of gastric biopsies and cultures of one antral gastric biopsy per subject were performed as previously described ([@B6]). DNA from the *H. pylori* pellet was isolated with DNAzol (Thermo Fisher Scientific) and then sheared and used to prepare a library for 250-bp paired-end sequencing with an Illumina MiSeq instrument. Sequencing reads were assembled *de novo* into contigs using CLC Genomics Workbench version 8.5 (CLC bio, Aarhus, Denmark). Calculated depth of coverage ranged from 36× to 142×. All genomes contained the *cag* pathogenicity island ([@B8]). Statistics for the assemblies are shown in [Table 1](#tab1){ref-type="table"}. Draft sequences were annotated using the NCBI Prokaryotic Genome Annotation Pipeline.

###### 

Statistics for Colombian *Helicobacter pylori* strains

  Strain ID    Accession no.                                                       Host residence                            No. of contigs \>200 bp   Coverage (×)   Genome size (bp)   *N*~50~ (bp)   Diagnosis                                  Age of host \[yr(s)\]   Estimated ancestry of host (%)          
  ------------ ------------------------------------------------------------------- ----------------------------------------- ------------------------- -------------- ------------------ -------------- ------------------------------------------ ----------------------- -------------------------------- ------ ------
  PZ5005_3A3   [MTWJ00000000](https://www.ncbi.nlm.nih.gov/nuccore/MTWJ00000000)   LR[^a^](#ngtab1.1){ref-type="table-fn"}   51                        65             1,672,956          77,172         NAG[^c^](#ngtab1.3){ref-type="table-fn"}   53                      16.4                             76.5   17.1
  PZ5006_3A3   [MTWK00000000](https://www.ncbi.nlm.nih.gov/nuccore/MTWK00000000)   LR                                        53                        57             1,643,170          101,990        NAG                                        45                      10                               79.6   10.4
  PZ5009_3A2   [MSYO00000000](https://www.ncbi.nlm.nih.gov/nuccore/MSYO00000000)   LR                                        53                        101            1,677,035          96,381         NAG                                        53                      22.7                             60.8   16.5
  PZ5016_3A3   [MTWL00000000](https://www.ncbi.nlm.nih.gov/nuccore/MTWL00000000)   LR                                        44                        38             1,644,424          80,627         MAG[^d^](#ngtab1.4){ref-type="table-fn"}   40                      19.6                             49.1   31.3
  PZ5019_3A3   [MTWM00000000](https://www.ncbi.nlm.nih.gov/nuccore/MTWM00000000)   LR                                        44                        44             1,681,561          103,042        IM                                         47                      23.4                             29.7   46.9
  PZ5033_3A2   [MTWN00000000](https://www.ncbi.nlm.nih.gov/nuccore/MTWN00000000)   LR                                        60                        142            1,656,908          130,584        IM                                         57                      11.8                             72.6   15.5
  SV328_2      [MTWO00000000](https://www.ncbi.nlm.nih.gov/nuccore/MTWO00000000)   HR[^b^](#ngtab1.2){ref-type="table-fn"}   56                        37             1,645,479          95,218         Dys[^e^](#ngtab1.5){ref-type="table-fn"}   54                      44.8                             4.3    50.9
  SV340_2      [MTWP00000000](https://www.ncbi.nlm.nih.gov/nuccore/MTWP00000000)   HR                                        53                        41             1,633,298          128,372        NAG                                        45                      16.6                             0.8    82.6
  SV355_2      [MTWQ00000000](https://www.ncbi.nlm.nih.gov/nuccore/MTWQ00000000)   HR                                        39                        41             1,635,304          125,154        IM[^f^](#ngtab1.6){ref-type="table-fn"}    45                      13.1                             1.8    85.1
  SV376_1      [MTWR00000000](https://www.ncbi.nlm.nih.gov/nuccore/MTWR00000000)   HR                                        207                       43             1,691,791          30,293         IM                                         55                      45.6                             7.6    46.8
  SV380_1      [MTWU00000000](https://www.ncbi.nlm.nih.gov/nuccore/MTWU00000000)   HR                                        40                        41             1,631,819          136,108        IM                                         43                      36.9                             0.7    62.5
  SV397_2      [MTWS00000000](https://www.ncbi.nlm.nih.gov/nuccore/MTWS00000000)   HR                                        47                        38             1,668,205          100,030        NAG[^g^](#ngtab1.7){ref-type="table-fn"}   45                      32.8                             1.4    65.8
  SV449_1      [MTWT00000000](https://www.ncbi.nlm.nih.gov/nuccore/MTWT00000000)   HR                                        41                        36             1,654,884          104,133        IM                                         42                      28.3                             9.2    62.5

LR, host is resident of area where risk for gastric cancer is low.

HR, host is resident of area where risk for gastric cancer is high.

NAG, nonatrophic gastritis.

MAG, multifocal atrophic gastritis.

Dys, dysplasia.

IM, intestinal metaplasia.

Diagnosis from corpus biopsy only. Severity of lesions may be underestimated due to lack of incisura and antrum biopsies.

Accession number(s). {#s1}
--------------------

The draft genome sequence projects presented here have been deposited at DDBJ/ENA/GenBank under the accession numbers shown in [Table 1](#tab1){ref-type="table"}. The versions described in this paper are the first versions (e.g., MTWJ01000000 to MTWT01000000).
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